- Home
- LUNG vs NSRX Comparison
LUNG vs NSRX Comparison
Compare LUNG & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- NSRX
- Stock Information
- Founded
- LUNG 1995
- NSRX N/A
- Country
- LUNG United States
- NSRX Israel
- Employees
- LUNG N/A
- NSRX N/A
- Industry
- LUNG Industrial Specialties
- NSRX Biotechnology: Pharmaceutical Preparations
- Sector
- LUNG Health Care
- NSRX Health Care
- Exchange
- LUNG Nasdaq
- NSRX Nasdaq
- Market Cap
- LUNG 65.6M
- NSRX 73.0M
- IPO Year
- LUNG 2020
- NSRX 2025
- Fundamental
- Price
- LUNG $1.59
- NSRX $8.01
- Analyst Decision
- LUNG Buy
- NSRX
- Analyst Count
- LUNG 7
- NSRX 0
- Target Price
- LUNG $7.66
- NSRX N/A
- AVG Volume (30 Days)
- LUNG 480.4K
- NSRX 33.0K
- Earning Date
- LUNG 10-29-2025
- NSRX 01-01-0001
- Dividend Yield
- LUNG N/A
- NSRX N/A
- EPS Growth
- LUNG N/A
- NSRX N/A
- EPS
- LUNG N/A
- NSRX N/A
- Revenue
- LUNG $90,549,000.00
- NSRX N/A
- Revenue This Year
- LUNG $10.30
- NSRX N/A
- Revenue Next Year
- LUNG $14.72
- NSRX N/A
- P/E Ratio
- LUNG N/A
- NSRX N/A
- Revenue Growth
- LUNG 18.24
- NSRX N/A
- 52 Week Low
- LUNG $1.47
- NSRX $7.23
- 52 Week High
- LUNG $9.37
- NSRX $9.99
- Technical
- Relative Strength Index (RSI)
- LUNG 39.52
- NSRX N/A
- Support Level
- LUNG $1.54
- NSRX N/A
- Resistance Level
- LUNG $1.63
- NSRX N/A
- Average True Range (ATR)
- LUNG 0.12
- NSRX 0.00
- MACD
- LUNG 0.02
- NSRX 0.00
- Stochastic Oscillator
- LUNG 12.90
- NSRX 0.00
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.